Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Vanesa Gutiérrez-Calderón"'
Autor:
Jordi Rubió-Casadevall, Beatriz Cirauqui Cirauqui, Javier Martinez Trufero, Maria Plana Serrahima, Almudena García Castaño, Alberto Carral Maseda, Lara Iglesias Docampo, Pedro Pérez Segura, Isaac Ceballos Lenza, Vanesa Gutiérrez Calderón, José Fuster Salvà, Carolina Pena Álvarez, Irene Hernandez, Edel del Barco Morillo, Manuel Chaves Conde, Joaquina Martínez Galán, Marisa Durán Sánchez, Vanesa Quiroga, Eugenia Ortega, Ricard Mesia
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesThe aim of this study was to confirm the efficacy of the ERBITAX scheme (paclitaxel 80 mg/m2 weekly and cetuximab 400 mg/m2 loading dose, and then 250 mg/m2 weekly) as first-line treatment for patients with recurrent/metastatic squamous cel
Externí odkaz:
https://doaj.org/article/2c2ce3b877f44930902325a31aadefe0
Autor:
Vanesa Gutiérrez Calderón, Alexandra Cantero González, Laura Gálvez Carvajal, Yolanda Aguilar Lizarralde, Antonio Rueda Domínguez
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Squamous cell carcinoma of oral cavity (OCSCC) accounts for approximately 25% of cases of head and neck squamous cell carcinoma (HNSCC). Tobacco and alcohol consumption are the main risk factors for both cancers. Surgical resection, combined with adj
Externí odkaz:
https://doaj.org/article/3c485da470d34a59bf1d986d216bfb08
Autor:
Luis Paz‐Ares, David R. Spigel, Yuanbin Chen, Maria Jove, Oscar Juan‐Vidal, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe Caro, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Xiaopan Yao, Jaba Kokhreidze, Santiago Ponce, Paul A. Bunn
Publikováno v:
CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
RESILIENT (NCT03088813) is a phase 2/3 study assessing the safety, tolerability, and efficacy of liposomal irinotecan monotherapy in patients with small cell lung cancer and disease progression on/after first-line platinum-based therapy. Here, we pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680d158944be2a7768767d9b0fb91f2a
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15599
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15599
Autor:
Alexandra Cantero González, Antonio Rueda Dominguez, Vanesa Gutiérrez Calderón, Laura Galvez Carvajal, Yolanda Aguilar Lizarralde
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Squamous cell carcinoma of oral cavity (OCSCC) accounts for approximately 25% of cases of head and neck squamous cell carcinoma (HNSCC). Tobacco and alcohol consumption are the main risk factors for both cancers. Surgical resection, combined with adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce4fea16149cd58a662c82e0b9961ff
https://doaj.org/article/3c485da470d34a59bf1d986d216bfb08
https://doaj.org/article/3c485da470d34a59bf1d986d216bfb08
Bronchiolitis obliterans organizing pneumonia simulating progression in bronquioloalveolar carcinoma
Autor:
Julia Alcaide García, Manuel Benavides Orgaz, Ester Villar Chamorro, Silvia Gil Calle, Vanesa Gutiérrez Calderón, Manuel Cobo Dols, Inmaculada Alés Díaz
Publikováno v:
Clinical and Translational Oncology. 8:133-135
Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathologic syndrome with characteristic features. The diagnosis of BOOP requires the presence of a combination of pathological, clinical, and radiological features. We report the case o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8329343628d4ea1b91393fff3e0bcd5f
https://doi.org/10.1007/s12094-006-0171-0
https://doi.org/10.1007/s12094-006-0171-0
Autor:
Silvia Gil Calle, Inmaculada Alés Díaz, Francisco Carabante Ocón, Rosa Algarra García, José Peláez Angulo, Julia Alcaide García, Ester Villar Chamorro, Vanesa Gutiérrez Calderón, Carlos Fuente Lupiáñez, Manuel Cobo Dols, Santiago Muñoz Gallardo, Manuel Benavides Orgaz, Alvaro Montesa Pino
Publikováno v:
Clinical and Translational Oncology. 7:409-411
Primary signet-ring cell carcinoma of the prostate is infrequent and even more so as secondary spread of this pathologic sub-type to the prostate. We describe the sixth reported case with a diagnosis of a secondary signet-ring cell tumour of the pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::648da2ae8fe147b6d7eecc85a774ccbc
https://doi.org/10.1007/bf02716587
https://doi.org/10.1007/bf02716587
Autor:
Mariano Provencio, Vicente Alberola, Bartomeu Massuti, Manuel Cobo, Miguel Taron, Carlos Camps, Manuel Domine, Nuria Viñolas, Rafael Rosell, Vanesa Gutiérrez-Calderón, Dolores Isla, Antonio Nieto, Vicente Alfaro, Pilar Lardelli
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 76(3)
Background Previous studies in sarcoma found that a composite gene signature, including high expression of nucleotide excision repair (NER) genes (XPG and/or ERCC1) and low expression of homologous recombination repair (HR) genes (BRCA1), identifies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f197e9fbbb4492eecd9cfa5e389052a
https://pubmed.ncbi.nlm.nih.gov/22197612
https://pubmed.ncbi.nlm.nih.gov/22197612
Autor:
Julia Alcalde García, Francisco Carabantes Ocón, Inmaculada Alés Díaz, Manuel Benavides Orgaz, Vanesa Gutiérrez Calderón, Silvia Gil Calle, Esther Villar Chamorro, Alvaro Montesa Pino, Juan José Bretón García, Manuel Cobo Dols
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(10)
Objective. We conducted this phase II trial to evaluate the efficacy and toxicity of the sequential nonplatinum combination chemotherapy consisting of gemcitabine (GEM) and vinorelbine (VNR) followed by weekly docetaxel (DOC) in patients with advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6308a0c704fdab08166f04f633785c
https://pubmed.ncbi.nlm.nih.gov/17074673
https://pubmed.ncbi.nlm.nih.gov/17074673
Autor:
Esther Villar-Chamorro, Vanesa Gutiérrez-Calderón, Juan J. Bretón-García, Álvaro Montesa-Pino, Inmaculada Alés-Díaz, Manuel Cobo-Dols, Manuel Benavides-Orgaz, Silvia Gil-Calle, Julia Alcalde-García, Francisco Carabantes-Ocón
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(7)
In this Phase I/II trial, the maximumtolerated dose (MTD) and activity of cisplatin plus vinorelbine (VRL) administered in continuous infusion as first-line treatment of advanced non small cell lung cancer (NSCLC) was determined in 12 consecutive che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd7438e8572d63f36b9e0c3f7337fb7a
https://pubmed.ncbi.nlm.nih.gov/16870542
https://pubmed.ncbi.nlm.nih.gov/16870542
Autor:
Manuel Cobo-Dols, Inmaculada Alés-Díaz, Julia Alcaide-García, Vanesa Gutiérrez-Calderón, Álvaro Montesa-Pino, Ester Villar-Chamorro, Silvia Gil-Calle, Manuel Benavides-Orgaz
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(4)
Renal cell carcinoma is an uncommon tumor in adults. metastasis in the nasal fossa is rare, and can become apparent as a result of repeated epistaxis. We report a patient with renal cell carcinoma presenting with epistaxis secondary to a metastasis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7554e3bfab8748edfd95e97b4ebeef3
https://pubmed.ncbi.nlm.nih.gov/16648109
https://pubmed.ncbi.nlm.nih.gov/16648109